https://www.elsevier.es/en-revista-vacunas-english-edition--259-articulo-separ-recommendations-new-challenges-on-S2445146021000388
The scientific community realised that mass vaccination of the population was the best tool to combat SARS-CoV-2 from the moment it was declared a
separrecommendationsnewchallengescovid
https://www.elsevier.com/health/clinical-resources/respiratory-diseases
Explore the latest nursing skills, patient education and more evidence-based resources on COVID-19, RSV, and Influenza.
infectious diseasesrespiratory
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1200937/full
Growing evidence indicates that variations in the composition of the gut microbiota are linked to the onset and progression of chronic respiratory diseases (...
gut microbiotarespiratory diseasesfrontiersassociationschronic
https://odysee.com/$/embed/EP8-Radical/93141ffa7a818f56b65173802a614f39bf7b6f9c?r=4VtDAHem1XoctwsoKPfrd9m8S9mjeYrh
We speak at length in this special episode to whistleblower Dr Mike Yeadon, author of The Covid Lies and former global Head of Respiratory Diseases for Pfizer.
respiratory diseasespfizerformerglobalhead
https://www.phongkhamcaythongxanh.org.vn/en/treatment-for-respiratory-diseases-without-overusing-antibiotics/
The weather in North of Vietnam is in transition from Winter to Spring. During this period, children often suffer from respiratory diseases. In order to help...
respiratory diseasesworkshoptreatmentwithoutantibiotics
https://www.clinicaltrialsarena.com/analyst-comment/cgt-landscape-respiratory-diseases/
Nov 28, 2025 - One of the biggest challenges to the CGT landscape over the last few years has been the drop in venture financing from $35.9bn in 2021 to $23.3bn in 2024.
gene therapyrespiratory diseasescelllandscapefuture
https://pubmed.ncbi.nlm.nih.gov/40295474/
Biological mechanisms underlying multimorbidity remain elusive. To dissect the polygenic heterogeneity of multimorbidity in twelve complex traits across...
dissectingcrosspopulationpolygenicheterogeneity
https://www.prnewswire.com/news-releases/global-respiratory-diseases-drugs-market-report-2021-market-is-expected-to-decline-from-90-32-billion-in-2020-to-79-82-billion-in-2021---long-term-forecast-to-2025--2030--301240921.html
/PRNewswire/ -- The "Respiratory Diseases Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to...
respiratory diseasesglobaldrugsmarketreport